DROPERIDOL SXP droperidol 5 mg/2 mL solution for injection glass ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

droperidol sxp droperidol 5 mg/2 ml solution for injection glass ampoule

southern cross pharma pty ltd - droperidol, quantity: 5 mg - injection, solution - excipient ingredients: mannitol; tartaric acid; sodium hydroxide; water for injections - anaesthesia droperidol sxp injection is indicated to produce tranquillisation and to reduce the incidence of nausea and vomiting in surgical and diagnostic procedures for premedication, induction, and as an adjunct in the maintenance of general and regional anaesthesia in neuroleptanalgesia in which droperidol sxp injection is given concurrently with a narcotic analgesic, to aid in producing tranquillity and decreasing anxiety and pain.,psychiatry the management of severe agitation, hyperactivity, or aggressiveness in psychotic disorders, including schizophrenic reaction and the manic type of manic depressive illness, or in disturbed states, such as some types of acute brain syndrome and in nonpsychotic acute excitation states.

DROPERIDOL SXP droperidol 2.5 mg/1 mL solution for injection glass ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

droperidol sxp droperidol 2.5 mg/1 ml solution for injection glass ampoule

southern cross pharma pty ltd - droperidol, quantity: 2.5 mg - injection, solution - excipient ingredients: mannitol; tartaric acid; sodium hydroxide; water for injections - anaesthesia droperidol sxp injection is indicated to produce tranquillisation and to reduce the incidence of nausea and vomiting in surgical and diagnostic procedures for premedication, induction, and as an adjunct in the maintenance of general and regional anaesthesia in neuroleptanalgesia in which droperidol sxp injection is given concurrently with a narcotic analgesic, to aid in producing tranquillity and decreasing anxiety and pain.,psychiatry the management of severe agitation, hyperactivity, or aggressiveness in psychotic disorders, including schizophrenic reaction and the manic type of manic depressive illness, or in disturbed states, such as some types of acute brain syndrome and in nonpsychotic acute excitation states.

DROPERIDOL 2.5 mg/1 mL MEDSURGE droperidol 2.5 mg/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

droperidol 2.5 mg/1 ml medsurge droperidol 2.5 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - droperidol, quantity: 2.5 mg/ml - injection, solution - excipient ingredients: tartaric acid; water for injections; sodium hydroxide; mannitol - anaesthesia droperidol solution for injection is indicated to produce tranquillisation and to reduce the incidence of nausea and vomiting in surgical and diagnostic procedures; for premedication, induction, and as an adjunct in the maintenance of general and regional anaesthesia; in neuroleptanalgesia in which droperidol solution for injection is given concurrently with a narcotic analgesic, to aid in producing tranquillity and decreasing anxiety and pain.,psychiatry the management of severe agitation, hyperactivity, or aggressiveness in psychotic disorders, including schizophrenic reaction and the manic type of manic depressive illness, or in disturbed states, such as some types of acute brain syndrome and in nonpsychotic acute excitation states.

DROPERIDOL PANPHARMA droperidol 5 mg/2 mL solution for injection, ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

droperidol panpharma droperidol 5 mg/2 ml solution for injection, ampoule

panpharma australia pty ltd - droperidol, quantity: 2.5 mg/ml - injection, solution - excipient ingredients: mannitol; tartaric acid; sodium hydroxide; nitrogen; water for injections - anaesthesia droperidol panpharma injection is indicated to produce tranquillisation and to reduce the incidence of nausea and vomiting in surgical and diagnostic procedures; for premedication, induction, and as an adjunct in the maintenance of general and regional anaesthesia; in neuroleptanalgesia in which droperidol panpharma injection is given concurrently with a narcotic analgesic, to aid in producing tranquillity and decreasing anxiety and pain.,psychiatry the management of severe agitation, hyperactivity, or aggressiveness in psychotic disorders, including schizophrenic reaction and the manic type of manic depressive illness, or in disturbed states, such as some types of acute brain syndrome and in nonpsychotic acute excitation states.

DROPERIDOL PANPHARMA droperidol 1.25 mg/2.5 mL solution for injection, ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

droperidol panpharma droperidol 1.25 mg/2.5 ml solution for injection, ampoule

panpharma australia pty ltd - droperidol, quantity: 0.5 mg/ml - injection, solution - excipient ingredients: mannitol; tartaric acid; sodium hydroxide; nitrogen; water for injections - anaesthesia droperidol panpharma injection is indicated to produce tranquillisation and to reduce the incidence of nausea and vomiting in surgical and diagnostic procedures; for premedication, induction, and as an adjunct in the maintenance of general and regional anaesthesia; in neuroleptanalgesia in which droperidol panpharma injection is given concurrently with a narcotic analgesic, to aid in producing tranquillity and decreasing anxiety and pain.,psychiatry the management of severe agitation, hyperactivity, or aggressiveness in psychotic disorders, including schizophrenic reaction and the manic type of manic depressive illness, or in disturbed states, such as some types of acute brain syndrome and in nonpsychotic acute excitation states.

DROPERIDOL PANPHARMA droperidol 2.5 mg/1 mL solution for injection, ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

droperidol panpharma droperidol 2.5 mg/1 ml solution for injection, ampoule

panpharma australia pty ltd - droperidol, quantity: 2.5 mg/ml - injection, solution - excipient ingredients: mannitol; tartaric acid; sodium hydroxide; nitrogen; water for injections - anaesthesia droperidol panpharma injection is indicated to produce tranquillisation and to reduce the incidence of nausea and vomiting in surgical and diagnostic procedures; for premedication, induction, and as an adjunct in the maintenance of general and regional anaesthesia; in neuroleptanalgesia in which droperidol panpharma injection is given concurrently with a narcotic analgesic, to aid in producing tranquillity and decreasing anxiety and pain.,psychiatry the management of severe agitation, hyperactivity, or aggressiveness in psychotic disorders, including schizophrenic reaction and the manic type of manic depressive illness, or in disturbed states, such as some types of acute brain syndrome and in nonpsychotic acute excitation states.

DROPERIDOL injection, solution United States - English - NLM (National Library of Medicine)

droperidol injection, solution

hospira, inc. - droperidol (unii: o9u0f09d5x) (droperidol - unii:o9u0f09d5x) - droperidol 2.5 mg in 1 ml - droperidol injection is indicated to reduce the incidence of nausea and vomiting associated with surgical and diagnostic procedures. droperidol is contraindicated in patients with known or suspected qt prolongation (i.e., qtc interval greater than 440 msec for males or 450 msec for females). this would include patients with congenital long qt syndrome. droperidol is contraindicated in patients with known hypersensitivity to the drug. droperidol is not recommended for any use other than for the treatment of perioperative nausea and vomiting in patients for whom other treatments are ineffective or inappropriate (see warnings).

DROPERIDOL injection, solution United States - English - NLM (National Library of Medicine)

droperidol injection, solution

american regent, inc. - droperidol (unii: o9u0f09d5x) (droperidol - unii:o9u0f09d5x) - droperidol 2.5 mg in 1 ml - droperidol injection is indicated to reduce the incidence of nausea and vomiting associated with surgical and diagnostic procedures. droperidol is contraindicated in patients with known or suspected qt prolongation (i.e., qtc interval greater than 440 msec for males or 450 msec for females). this would include patients with congenital long qt syndrome. droperidol is contraindicated in patients with known hypersensitivity to the drug. droperidol is not recommended for any use other than for the treatment of perioperative nausea and vomiting in patients for whom other treatments are ineffective or inappropriate (see warnings).

DROPERIDOL injection solution United States - English - NLM (National Library of Medicine)

droperidol injection solution

cardinal health - droperidol (unii: o9u0f09d5x) (droperidol - unii:o9u0f09d5x) - droperidol 2.5 mg in 1 ml

DROPERIDOL AJS droperidol 2.5 mg/1 mL solution for injection glass ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

droperidol ajs droperidol 2.5 mg/1 ml solution for injection glass ampoule

southern cross pharma pty ltd - droperidol, quantity: 2.5 mg - injection, solution - excipient ingredients: mannitol; tartaric acid; sodium hydroxide; water for injections - anaesthesia droperidol ajs injection is indicated to produce tranquillisation and to reduce the incidence of nausea and vomiting in surgical and diagnostic procedures for premedication, induction, and as an adjunct in the maintenance of general and regional anaesthesia in neuroleptanalgesia in which droperidol ajs injection is given concurrently with a narcotic analgesic, to aid in producing tranquillity and decreasing anxiety and pain.,psychiatry the management of severe agitation, hyperactivity, or aggressiveness in psychotic disorders, including schizophrenic reaction and the manic type of manic depressive illness, or in disturbed states, such as some types of acute brain syndrome and in nonpsychotic acute excitation states.